Evaluation of the modern indocyanine green dye in the breast cancer scenario

Not Applicable

• Conditions: Breast cancer; Sentinel lymph node; E01.789.625

• Registration Number: RBR-6d36dgq
• Lead Sponsor: niversidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-05-24
• Study Start: 2022-08-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Clinically negative axillary breast cancer; present surgical indication

Exclusion Criteria

T4 (chest wall or skin involvement or inflammatory); N1 (single lymph node affected); N2 (conglomerate of affected lymph nodes; N3 (supra or infraclavicular lymph node involvement; Having undergone neoadjuvant chemotherapy

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected outcome 1<br>It is expected to find a high rate of sentinel lymph node identification through fluorescence;Endpoint found 1<br>A higher rate of sentinel lymph node detection was observed in patients undergoing the sentinel lymph node technique with the combined use of dyes (100%) compared to isolated dyes (patent blue: 78.8%, indocyanine green: 93.9%)

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected.